Skip to main content

Advertisement

Log in

Matrix Metalloproteinase-1 (MMP1) Polymorphism is Associated with Lowered Risk of Nasopharyngeal Carcinoma in Asian Population

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Data on the association between −1607 1G > 2G polymorphism in the promoter region of matrix metalloproteinase-1 (MMP1) and nasopharyngeal carcinoma (NPC) are conflicting. The aim of this study was to confirm whether this polymorphism was a causative factor of NPC. We searched PubMed, Embase, and China National Knowledge Infrastructure (CNKI) for studies on the present topic. A total of four publications (1,044 NPC patients and 1,284 healthy control subjects) were included and meta-analysis was performed to assess the association between −1607 1G > 2G polymorphism and NPC risk. Odds ratio (OR) with 95 % confidence interval (95 % CI) was calculated for 1G1G versus 2G2G, 1G1G + 1G2G versus 2G2G, 1G1G versus 1G2G + 2G2G, 1G versus 2G, and 1G2G versus 2G2G contrast models. Meta-analysis results showed significantly reduced risk of NPC associated with the 1G1G versus 2G2G, 1G versus 2G and 1G2G versus 2G2G contrast models (OR = 0.61, 95 % CI 0.49–0.77; OR = 0.78, 95 % CI 0.65–0.92; OR = 0.86, 95 % CI 0.74–0.99, respectively). When we continued to perform subgroup analysis by ethnicity, the significant association persisted in Asian population and was most pronounced under the 1G2G versus 2G2G model (OR = 0.85, 95 % CI 0.73–0.99). These data suggested that MMP1 −1607 1G > 2G polymorphism was associated with reduced risk of NPC, particularly in the population of Asian descent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Parkin, D. M., Whelan, S., Ferlay, J., Teppo, L., Thomas, D. B., et al. (2002). Cancer incidence in five continents, IARC Scientific Publications No. 155 (Vol. III). Lyon: IARC.

  2. Cao, S. M., Simons, M. J., & Qian, C. N. (2011). The prevalence and prevention of nasopharyngeal carcinoma in China. Chinese Journal Of Cancer, 30(2), 114–119.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Chang, E. T., & Adami, H. O. (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiology Biomarkers & Prevention, 15(10), 1765–1777.

    Article  CAS  Google Scholar 

  4. Jung, P. F. (1965). Familial tendency of nasopharyngeal carcinoma; a report of cases. Pacific Medicine and Surgery, 73, 242–243.

    CAS  PubMed  Google Scholar 

  5. Ko, J. Y., et al. (1998). Familial clustering of nasopharyngeal carcinoma. Otolaryngology-Head and Neck Surgery, 118(5), 736–737.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang, F., & Zhang, J. (1999). Clinical hereditary characteristics in nasopharyngeal carcinoma through Ye-Liang’s family cluster. Chinese Medical Journal, 112(2), 185–187.

    CAS  PubMed  Google Scholar 

  7. Egeblad, M., & Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer, 2(3), 161–174.

    Article  CAS  PubMed  Google Scholar 

  8. Stetler-Stevenson, W. G., Liotta, L. A., & Kleiner, D. E, Jr. (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB Journal, 7(15), 1434–1441.

    CAS  PubMed  Google Scholar 

  9. Liotta, L. A., DeVita, V. T., Helman, S., and Rosenberg, S. A., (Eds.). (1989) Cancer: Principles and Practice of Oncology (Vol I, pp 98–115). New York: J.B. Lippincott.

  10. Fink, K., & Boratynski, J. (2012). The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis. Postepy Higieny I Medycyny Doswiadczalnej (Online), 66, 609–628.

    Article  Google Scholar 

  11. Tahara, K., et al. (2010). Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer. Annals of Surgical Oncology, 17(12), 3362–3369.

    Article  PubMed  Google Scholar 

  12. Pradhan-Palikhe, P., et al. (2010). Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer. Oral Oncology, 46(7), 514–518.

    Article  CAS  PubMed  Google Scholar 

  13. Li, M., et al. (2010). Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer, 69(3), 341–347.

    Article  PubMed  Google Scholar 

  14. Rutter, J. L., et al. (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Research, 58(23), 5321–5325.

    CAS  PubMed  Google Scholar 

  15. Hinoda, Y., et al. (2002). Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. International Journal of Cancer, 102(5), 526–529.

    Article  CAS  Google Scholar 

  16. Su, L., et al. (2006). Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis, 27(5), 1024–1029.

    Article  CAS  PubMed  Google Scholar 

  17. Nishizawa, R., et al. (2007). The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer, 7, 187.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Nasr, H. B., et al. (2007). Matrix metalloproteinase-1 (−1607) 1G/2G and −9 (−1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clinica Chimica Acta, 384(1–2), 57–63.

    Article  Google Scholar 

  19. Zhou, G., et al. (2007). Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Human Mutation, 28(11), 1091–1097.

    Article  CAS  PubMed  Google Scholar 

  20. Lau, J., Ioannidis, J. P., & Schmid, C. H. (1997). Quantitative synthesis in systematic reviews. Annals of Internal Medicine, 127(9), 820–826.

    Article  CAS  PubMed  Google Scholar 

  21. Higgins, J. P., et al. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Mantel, N., & Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute, 22(4), 719–748.

    CAS  PubMed  Google Scholar 

  23. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.

    Article  CAS  PubMed  Google Scholar 

  24. Egger, M., et al. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629–634.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Kondo, S., et al. (2005). Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. International Journal of Cancer, 115(3), 368–376.

    Article  CAS  Google Scholar 

  26. Gao, W., Sui, J., Wang, B., Li, X., Zhang, C., Wen, S., et al. (2010). MMP-1(-1607)1G/2G gene polymorphism and susceptibility to nasopharyngeal carcinoma in Han population in Yunnan China. Chinese Archives of Otolaryngology-Head and Neck Surgery, 17(3), 116–120.

    Google Scholar 

  27. Gallicchio, L., et al. (2006). Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. International Journal of Cancer, 119(5), 1125–1135.

    Article  CAS  Google Scholar 

  28. Zhou, B., et al. (2009). A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Letters, 275(1), 72–76.

    Article  CAS  PubMed  Google Scholar 

  29. Nong, L. G., et al. (2009). Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA and Cell Biology, 28(10), 507–513.

    Article  CAS  PubMed  Google Scholar 

  30. Deng, L., et al. (2002). Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 34(1), 16–20.

    CAS  Google Scholar 

  31. Jalbout, M., et al. (2003). Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Letters, 193(1), 75–81.

    Article  CAS  PubMed  Google Scholar 

  32. Zhang, C., et al. (2013). Association between MMP1 −1607 1G > 2G polymorphism and head and neck cancer risk: a meta-analysis. PLoS One, 8(2), e56294.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have not declared any conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chao Lv.

Additional information

Zhen Li and Hongzhou Ge have contributed equally to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Z., Ge, H., Xie, YG. et al. Matrix Metalloproteinase-1 (MMP1) Polymorphism is Associated with Lowered Risk of Nasopharyngeal Carcinoma in Asian Population. Cell Biochem Biophys 71, 999–1004 (2015). https://doi.org/10.1007/s12013-014-0299-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0299-4

Keywords

Navigation